Ketamine to prevent suicide?

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

Ketamine’s controversial role in treating depression has been boosted by a new randomised controlled trial showing it significantly and rapidly reduces suicidal ideation.

Among a group of 80 severely depressed individuals already on pharmacotherapy, the US researchers found that a single, subanaesthetic infusion of ketamine was associated with a greater reduction in clinically significant suicidal ideation within 24 hours than a control midazolam infusion.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof William Kemp

A/Prof William Kemp

Cardiovascular Risk and Fatty Liver Disease

Dr Ryan De Cruz

Dr Ryan De Cruz

Importance of Early & Effective Treatment of Mild to Moderate Acne

Prof Merlin Thomas

Prof Merlin Thomas

SGLT2s and Renal Protection

Dr Adam Nelson

Dr Adam Nelson

CV Medications – Practical Strategies to Improve Compliance

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

To what extent is government messaging contributing to public perception of "greedy doctors"?

Significantly

0%

Slightly contributing

0%

Not at all contributing

0%

I don't think there is a public perception of greedy doctors

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Cardiovascular Risk and Fatty Liver Disease

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

A/Prof William Kemp

Gastroenterologist and Hepatologist; Alfred Hospital Melbourne, Monash University School of Translational Medicine

We invite you to our next free webcast, where I will discuss cardiovascular risk and fatty liver disease. Earn up to 4 hours CPD. RACGP & ACRRM accredited.